HUMPHREY RACHEL

USNatural personDirector

Insider

HUMPHREY RACHEL

USNatural personDirector

Transactions

Issuers

Buys / Sells

0/5

Last tx

24 Mar 2026

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
CytomX Therapeutics, Inc.	90,000	reported	25 Jan 2019	tx 14+445,234−110,234
Black Diamond Therapeutics, Inc.	60,000	reported	17 Feb 2021	tx 3+220,000
Pyxis Oncology, Inc.	45,867	reported	24 Mar 2026	tx 8+415,871−15,496

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
14 Apr 2025	SALE	Pyxis Oncology, Inc.	1,400	0.97 USD
21 Apr 2025	SALE	Pyxis Oncology, Inc.	13,896	1.03 USD
17 Apr 2025	SALE	Pyxis Oncology, Inc.	200	0.97 USD
24 Mar 2026	GRANT_AWARD	Pyxis Oncology, Inc.	45,867	0.00 USD	deriv
31 Mar 2025	GRANT_AWARD

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, HKEX, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
CytomX Therapeutics, Inc.	90,000	reported	25 Jan 2019	tx 14+445,234−110,234
Black Diamond Therapeutics, Inc.	60,000	reported	17 Feb 2021	tx 3+220,000
Pyxis Oncology, Inc.	45,867	reported	24 Mar 2026	tx 8+415,871−15,496

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
14 Apr 2025	SALE	Pyxis Oncology, Inc.	1,400	0.97 USD
21 Apr 2025	SALE	Pyxis Oncology, Inc.	13,896	1.03 USD
17 Apr 2025	SALE	Pyxis Oncology, Inc.	200	0.97 USD
24 Mar 2026	GRANT_AWARD	Pyxis Oncology, Inc.	45,867	0.00 USD	deriv
31 Mar 2025	GRANT_AWARD